201 related articles for article (PubMed ID: 16955136)
1. Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome.
Gladwin MT
J Clin Invest; 2006 Sep; 116(9):2330-2. PubMed ID: 16955136
[TBL] [Abstract][Full Text] [Related]
2. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
Stasch JP; Schmidt PM; Nedvetsky PI; Nedvetskaya TY; H S AK; Meurer S; Deile M; Taye A; Knorr A; Lapp H; Müller H; Turgay Y; Rothkegel C; Tersteegen A; Kemp-Harper B; Müller-Esterl W; Schmidt HH
J Clin Invest; 2006 Sep; 116(9):2552-61. PubMed ID: 16955146
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
5. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
[TBL] [Abstract][Full Text] [Related]
6. Effects of hydrogen peroxide on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries.
Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T
Free Radic Res; 2015; 49(12):1479-87. PubMed ID: 26334090
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
Meurer S; Pioch S; Pabst T; Opitz N; Schmidt PM; Beckhaus T; Wagner K; Matt S; Gegenbauer K; Geschka S; Karas M; Stasch JP; Schmidt HH; Müller-Esterl W
Circ Res; 2009 Jul; 105(1):33-41. PubMed ID: 19478201
[TBL] [Abstract][Full Text] [Related]
8. Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Dasgupta A; Bowman L; D'Arsigny CL; Archer SL
Clin Pharmacol Ther; 2015 Jan; 97(1):88-102. PubMed ID: 25670386
[TBL] [Abstract][Full Text] [Related]
9. Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure.
Boerrigter G; Costello-Boerrigter LC; Cataliotti A; Lapp H; Stasch JP; Burnett JC
Hypertension; 2007 May; 49(5):1128-33. PubMed ID: 17325237
[TBL] [Abstract][Full Text] [Related]
10. [Regulation of soluble guanylyl cyclase and its role in the treatment of cardiovascular diseases].
Guan WL; Dou D; Gao YS
Sheng Li Ke Xue Jin Zhan; 2011 Dec; 42(6):431-6. PubMed ID: 22363982
[No Abstract] [Full Text] [Related]
11. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
[TBL] [Abstract][Full Text] [Related]
12. Soluble guanylate cyclase: not a dull enzyme.
Boerrigter G; Burnett JC
Circulation; 2009 Jun; 119(21):2752-4. PubMed ID: 19451346
[No Abstract] [Full Text] [Related]
13. NO-independent, haem-dependent soluble guanylate cyclase stimulators.
Stasch JP; Hobbs AJ
Handb Exp Pharmacol; 2009; (191):277-308. PubMed ID: 19089334
[TBL] [Abstract][Full Text] [Related]
14. NO- and haem-independent soluble guanylate cyclase activators.
Schmidt HH; Schmidt PM; Stasch JP
Handb Exp Pharmacol; 2009; (191):309-39. PubMed ID: 19089335
[TBL] [Abstract][Full Text] [Related]
15. Probing the presence of the ligand-binding haem in cellular nitric oxide receptors.
Roy B; Mo E; Vernon J; Garthwaite J
Br J Pharmacol; 2008 Apr; 153(7):1495-504. PubMed ID: 18204474
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm.
Martin E; Golunski E; Laing ST; Estrera AL; Sharina IG
Am J Physiol Heart Circ Physiol; 2014 Dec; 307(11):H1565-75. PubMed ID: 25239802
[TBL] [Abstract][Full Text] [Related]
17. Aging does not affect soluble guanylate cyclase redox state in mouse aortas.
Shimosato T; Tawa M; Iwasaki H; Imamura T; Okamura T
Physiol Rep; 2016 May; 4(10):. PubMed ID: 27233303
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP
Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020
[TBL] [Abstract][Full Text] [Related]
19. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase.
Majumder S; Rajaram M; Muley A; Reddy HS; Tamilarasan KP; Kolluru GK; Sinha S; Siamwala JH; Gupta R; Ilavarasan R; Venkataraman S; Sivakumar KC; Anishetty S; Kumar PG; Chatterjee S
Br J Pharmacol; 2009 Dec; 158(7):1720-34. PubMed ID: 19912234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
